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Comparison of results of whole-body magnetic 
resonance imaging scans and traditional imaging 
modalities in diagnostic management of chronic 
recurrent multifocal osteomyelitis
Jerzy Sułko1, Artur Oberc2
A b s t r a c t
Introduction: The diagnosis of chronic recurrent multifocal osteomyelitis 
(CRMO) is frequently the result of excluding other diseases. The only meth-
ods that provide images of the multicentricity of radiologically active foci 
are whole body bone scintigraphy (SCI) and whole body MRI (WBMRI). The 
objective of the study was to compare the results of WBMRI and traditional 
imaging modalities in CRMO.
Material and methods: The study group consisted of 20 children with the 
mean age of 9.5 years. WBMRI imaging was performed between June and 
December of 2014. The mean follow-up period after completion of the study 
was 35 months. All the patients included in the study were additionally sub-
jected to examination of clinically active CRMO foci by computed tomogra-
phy, classic radiographic diagnostic management and scintigraphy.
Results: All the patients manifested clinically active foci. In the group of the 
investigated patients, the highest number of foci in concordance with the 
clinical picture was noted in SCI – 29, followed by CT  – 22 and WBMRI – 21, 
while plain X-ray yielded the lowest number of positive results – 12.  
Conclusions: The results of the present study do not confirm the highest 
sensitivity of WBMRI in determining possible disease foci in CRMO as com-
pared to other imaging modalities. Higher sensitivity in detection of radio-
logically active foci in CRMO was noted in bone system scintigraphy. During 
the 35-month follow-up, none of the WBMRI-detected radiologically active 
and clinically silent foci underwent clinical activation.
Key words: whole body magnetic resonance imaging, chronic recurrent 
multifocal osteomyelitis diagnosis, whole-body magnetic resonance 
imaging.
Introduction 
Chronic recurrent multifocal osteomyelitis (CRMO) belongs to the 
group of non-bacterial osteitis (NBO). Chronic recurrent multifocal osteo-
myelitis is often the cause of marked diagnostic problems or else remains 
an undiagnosed disease entity. The diagnosis of CRMO is frequently the 
result of excluding other diseases when specific coexisting lesions and 
abnormalities are detected in imaging and laboratory studies. Unfortu-
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nately, imaging studies of CRMO-associated le-
sions do not provide uniform results.
Roderick et al. proposed the criteria of CRMO 
diagnosis termed the ”Bristol diagnostic criteria 
for CRMO” [1]. In keeping with the above criteria, 
a combination of the presence of clinical activity 
manifested as bone pain and/or widening of the 
bone outline, radiological activity manifested as 
typical lesions in X-ray, computed tomography 
(CT) and magnetic resonance imaging (MRI) im-
aging modalities, abnormalities in laboratory tests 
involving C-reactive protein (CRP) and characteris-
tic histopathological lesions in the biopsy allow for 
establishing the diagnosis of CRMO. It should be, 
however, emphasized that the histopathological 
findings characteristic of CRMO, namely inflamma-
tory symptoms with the presence of lymphocytes, 
plasma cells, histiocytes, T and B cells, CD-68-pos-
itive macrophages and bone marrow edema, are 
not always present, and yet CRMO is diagnosed 
[2, 3]. As stressed by Fritz et al., histopathology 
is significant with respect to ruling out malig-
nancy and infectious genesis [3, 4]. On the other 
hand, imaging studies of single skeletal fragments 
with clinically active foci do not provide a picture 
of multifocality, which was already described by 
Giedon when defining CRMO [5]. As mentioned 
by Fritz et al., the conformity of clinical symptoms 
and the characteristic image of multicentricity of 
radiologically active foci allow for abandoning the 
intention of collecting a section and establishing 
the diagnosis of CRMO [4]. 
In the diagnostic management of the disease, 
apart from laboratory tests, the first-line imaging 
modality is plain X-ray involving the part of the 
skeletal system in which – in keeping with the pa-
tient’s complaints – chronic pain is experienced 
or else widening of the bone outline is noted. At 
times, radiography does not demonstrate visible 
abnormalities in the bone structures. To extend 
the imaging diagnostic management, one may 
employ CT or MRI. These imaging modalities also 
include the region in which the patient reports 
pain. The only methods that provide an image 
of the multicentricity of radiologically active foci 
are whole body bone scintigraphy (SCI) and whole 
body MRI (WBMRI). Scintigraphy of the bone sys-
tem informs us about the activity of bone metab-
olism and increased isotope uptake in the pain-
ful region, but also of a possible location of foci 
characterized by an increased isotope uptake and 
situated in other regions. The SCI modality is at 
present more available and less expensive as com-
pared to WBMRI, but it does not meet the ALARA 
criteria (as low as reasonably achievable) in imag-
ing modalities in children [4, 6].
In recent years, the authors of reports address-
ing CRMO have been drawing attention to bene-
fits resulting from MRI involving the entire skeletal 
system, or the so-called whole body MRI, which 
may also demonstrate other disease foci. An addi-
tional asset of WBMRI is its positive evaluation in 
keeping with the ALARA criteria [4].
The authors decided to employ WBMRI in the 
patients with diagnosed CRMO they treated. The 
objective of the study was to assess the bone 
system with respect to the possible presence of 
other disease foci, even if they were clinically si-
lent. All the patients included in the study were 
additionally subjected to examination of clinically 
active CRMO foci by computed tomography, clas-
sic radiographic diagnostic management and scin-
tigraphy. In addition, the level of osteocalcin was 
determined in all the subjects. 
The prospective study was carried out through 
a research grant and was issued with permission 
of the Bioethics Committee, Jagiellonian Universi-
ty Medical College (No. KBET/41/B/2014).
Material and methods 
The study group consisted of 20 children at 
the mean age of 9.5 years (range: 2–14 years). 
The legal guardians of all the patients granted 
their informed consent to include the children 
in the study group. The group included 18 girls 
and 2 boys. All the children were diagnosed with 
non-bacterial osteitis (NBO), with the classic form 
of CRMO detected in 16 (80%) children and sy-
novitis acne pustulosis hyperostosis osteomyelitis 
(SAPHO) in 4 (20%) patients. All the children were 
diagnosed in 2013 or in early 2014. WBMRI imag-
ing was performed between June and December 
of 2014. The mean follow-up period after comple-
tion of the study was 35 months.
WBMRI imaging was performed using a  Sie-
mens Magnetom Avanto Tim 76 × 18 1.5T in the 
following sequences: TSE T1, TSE T2, trufi T2 and 
STIR. The scans were acquired in the sagittal and 
frontal planes and the layer thickness was 3 mm 
and 5 mm. The imaging study included the entire 
body of each patient. In keeping with the rec-
ommendations provided in the literature, no en-
hancement with IV contrast medium (gadolinium) 
administration was employed [7, 8]. None of the 
children required sedation. The average duration 
of WBMRI examination was 25 min. 
The analysis was based on descriptions of the 
results and on assessment of the CD-recorded 
images performed by the authors. The radiologist 
who interpreted the MRI scans did not know the 
location of the previously determined disease foci, 
but was aware of the diagnosis.
Clinically active foci were defined as pain, swell-
ing or local warming within the bone system per-
sisting for the past 4 weeks. On the other hand, 
radiologically active foci in WBMRI imaging were 
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defined as sites with increased signal intensity in 
the STIR sequence with a simultaneous signal in-
tensity decrease below the signal originating from 
the muscle tissue in the T1-dependent sequence. 
In turn, an isolated signal decrease in the T1-de-
pendent sequence without any changes in the 
STIR sequence was not regarded as a radiological-
ly active focus of CRMO. The above criteria are in 
accordance with the criteria proposed by Arnoldi 
et al. [9]. The size of the described foci was not 
taken into account.
The results were compared with the results of 
imaging studies of clinically active foci performed 
in the course of the previous diagnostic manage-
ment: plain X-ray, computed tomography and 
bone system scintigraphy. The results were eval-
uated together with laboratory determinations of 
the level of osteocalcin.
The mean follow-up period of 35 months al-
lowed for evaluating clinically silent foci with re-
spect to their clinical presentation; the foci were 
visualized in WBMRI as images of radiologically 
active lesions.
While evaluating plain X-ray pictures and com-
puted tomography scans, radiologically active foci 
were defined as regions of bone lysis, sclerotiza-
tion and regions of periosteal reactions. Similar 
abnormalities have also been described in the 
course of CRMO by other authors [1]. It should be 
emphasized that solely clinically active foci were 
evaluated, since only such foci were visualized 
employing the above imaging modalities.
In scintiscans, determinations included the up-
take of Tc-99m-labeled hydroxymethylene diphos-
phonate (MDP). The MDP activity varied accord-
ing to age and bodyweight of the patients. The 
average activity on investigation was 408 MBq 
(megabecquerels). None of the patients required 
sedation.
Results 
All the patients manifested clinically active foci, 
with the mean number of foci per person being 
3.15 (min. 1; max. 9). 
Depending on the employed imaging modality, 
variable numbers of radiologically active foci were 
determined. The data are presented in Table I.
The patients were analyzed with respect to the 
prevalence and location of clinically active foci – 
their location is presented in Table II.
Employing the aforementioned imaging mo-
dalities, the authors managed to determine the 
following number of radiologically active foci 
concurrent with clinically active foci: X-ray – 12, 
CT – 22, SCI – 29, WBMRI – 21. It should be em-
phasized that in the case of WBMRI, the authors 
acquired images of nine foci that were asymptom-
atic both at the time of the examination and in 
the subsequent 30-month follow-up. According to 
the results reported by other authors, 18–30% of 
radiologically active foci detected by WBMRI were 
also not confirmed by clinical symptoms [1, 7, 9]. 
The quoted reports did not provide any data on 
subsequent follow-up of clinically silent and radio-
logically active foci in WBMRI; nevertheless, the 
present observations did not confirm their activa-
tion within the 35-month follow-up.
In the group of the investigated patients, the 
highest number of foci in concordance with the 
clinical picture was noted in SCI, followed by CT 
and WBMRI, while plain X-ray yielded the lowest 
number of positive results. The low sensitivity of 
plain X-ray is also mentioned by other authors, 
Table I. Maximal, minimal and mean number of diagnosed radiologically active foci calculated per person depend-
ing on imaging modality
Imaging modality Mean number of foci per patient Minimal number of foci Maximal number of foci 
X-ray 0.6 0 2
CT 1.1 0 3
SCI 1.45 0 3
WBMRI 1.5 0 5
Table II. Prevalence and location of clinically active 
foci in the investigated patients
Location of clinically 
active foci
Number of clinically 
active foci
Clavicle 9
Knee 8
Spine 7
Hip 6
Ankle 4
Jaw 4
Shoulder 3
Wrist 3
Foot 3
Ribs 2
Scapula 1
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who contrast the imaging modality with the high 
sensitivity of WBMRI or MRI involving the local-
ized part of the body. Nevertheless, the literature 
on the subject lacks studies comparing particular 
imaging modalities.
Table III presents the obtained data along with 
the division into the number of patients: 
•	 column	2	–	patients	in	whom	radiologically	in-
active but clinically active foci were detected, 
•	 column	3	–	studies	demonstrating	single-focus	
radiologically active abnormalities,
•	 column	4	–	studies	demonstrating	radiological-
ly active abnormalities involving two or more 
foci.
At the same time, it should be emphasized that 
single-focus CRMO was noted in 6 patients, while 
two or more foci were seen in the remaining 14 child- 
ren. No relationship was noted suggesting that any 
of the analyzed imaging modalities was supe-
rior to others in diagnostic management of sin-
gle or multifocal CRMO. Of significance, however, 
was the fact that in multifocal disease, WBMRI 
demonstrated the highest number of radiological-
ly active foci devoid of clinical activity, frequent-
ly failing to show radiological activity in clinically 
involved regions. When comparing two imaging 
modalities that visualize the entire bone system, 
namely SCI and WBMRI, the authors selected 
14 patients with multifocal CRMO in order to com-
pare the sensitivity and accuracy of imaging mo-
dalities. The results are presented in Table IV.
While analyzing the results of osteocalcin de-
terminations in the investigated patients, the au-
thors noted the mean osteocalcin level of 37 ng/
ml (5–82), with the normal value used by the lab-
oratory being up to 13.4 ng/ml.
Table III. Comparison of the number of clinically active foci that did not manifest radiological activity depending 
on the imaging modality
Imaging modality Clinically active and  
radiologically inactive foci 
Single radiologically active 
focus 
Two or more radiologically 
active foci 
X-ray 10 8 2
CT 5 9 6
SCI 3 8 9
WBMRI 7 8 5
Table IV. Group of patients with multicenter CRMO compared with respect to the number of clinically and radio-
logically active foci in SCI and WBMRI
No. of  
patient 
Number of 
clinically active 
foci 
Number of 
radiologically 
active foci  
in SCI
SCI sensitivity 
(%) 
Number of 
radiologically 
active foci  
in WBMRI
WBMRI 
sensitivity (%)
Falsely 
positive foci in 
WBMRI
1 3 3 100 2 66 +
2 4 3 75 0 0 –
3 3 3 100 1 33 –
4 2 2 100 1 50 +
5 2 2 100 2 100 –
6 3 1 33 1 33 –
7 4 3 75 4 100 +
8 9 2 22 2 22 +
9 2 0 0 0 0 –
10 5 1 20 1 20 –
11 4 2 50 3 75 –
12 7 1 14 0 0 –
13 6 3 50 1 16 +
14 3 1 33 1 33 +
Mean 55 39
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No association was observed between the level 
of osteocalcin and sensitivity of the imaging mo-
dalities.
Also no correlation was noted between pain 
intensity and detectability in imaging modalities. 
In the case of patients with painless CRMO pre-
senting solely with widening of the bone outline, 
radiological abnormalities were equally common 
in the analyzed imaging modalities.
Discussion 
Chronic recurrent multifocal osteomyelitis is 
an atypical disease that is difficult to diagnose 
and thus often escapes detection or is misdiag-
nosed. One of the characteristic properties of 
the disease is the presence of several foci in the 
bone system; the foci may be clinically active or 
non-active. Thus, they may be “clinically silent”. 
The WBMRI imaging modality suggested in re-
cent publications makes it possible to search for 
such foci in the bone system. Therefore, perform-
ing the aforementioned examination extends the 
diagnostic management of the disease and may 
also allow for detection of other foci in the bone 
system, which might be an element of a  clinical 
confirmation of CRMO diagnosis. Detecting the 
presence of more than one focus, and in partic-
ular of foci that are symmetrically situated in the 
bone system, suggests the diagnosis of CRMO in 
no uncertain terms [2, 10]. In turn, detection of 
radiologically active foci in the vertebral bodies 
is an indication for implementing CRMO therapy 
and allows avoidance of complications associated 
with clinical activation of foci [9, 11, 12].
Another aim of the present WBMRI study was 
to assess the bone system with respect to the 
presence of other radiologically active and clini-
cally inactive foci.
The results demonstrated that in patients with 
CRMO, the best correlation between the detected 
clinically active and radiologically active foci was 
achieved in scintigraphy. 
The present authors determined a group of pa-
tients with multifocal CRMO (Table III) and, sim-
ilarly as in the case of other investigators, they 
confirmed the observation of multifocal presence 
of abnormalities in the majority of patients – in 
the present material, this phenomenon was noted 
in 70% of the subjects [13, 14]. 
On the other hand, the present study did not 
confirm the extremely high detectability rate of 
disease foci or, in other words, sensitivity in de-
tection of abnormalities in the bone system that 
was reported by other authors [14]. Possibly, the 
issue underlying the discrepancies is the method 
used in the study, e.g. model of MRI scanner. Per-
haps other foci of bone abnormalities appear at 
various times in the course of the disease and this 
is a decisive factor in detecting their presence or 
absence. 
Is seems, however, that particularly in view of 
recently published reports, whole-body MRI is di-
agnostically important; from the viewpoint of the 
present authors, it is worthwhile to repeat a simi-
lar study including larger groups of patients. 
In conclusion, the results of the present study 
do not confirm the highest sensitivity of WBMRI 
in determining possible disease foci in CRMO as 
compared to other imaging modalities. Higher 
sensitivity in detection of radiologically active foci 
in CRMO has been noted in bone system scintig-
raphy. WBMRI allows for detecting the highest 
number of radiologically active foci when clinical 
activity is absent. During the 35-month follow-up, 
none of the WBMRI-detected radiologically active 
and clinically silent foci underwent clinical activa-
tion. The experience in employing whole body MRI 
presented in the literature and the present obser-
vations suggest that this examination should be 
performed in all patients diagnosed with CRMO in 
order to confirm the diagnosis.
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